---
title: "The DRG/DIP sector has seen a significant rise, with Winning Health increasing by over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227139421.md"
description: "The DRG/DIP sector has seen a significant rise, with Winning Health up over 10%, followed by Century, Guoxin Health, WJP, Huaping Co., Ltd., Neusoft, and others"
datetime: "2025-02-05T01:49:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227139421.md)
  - [en](https://longbridge.com/en/news/227139421.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227139421.md)
generator: "portal-rs"
---

# The DRG/DIP sector has seen a significant rise, with Winning Health increasing by over 10%

The DRG/DIP sector has seen a significant rise, with Winning Health up over 10%, followed by Century, GuoXin Health, WJP, Huaping Co., Ltd., and Neusoft also experiencing gains

### Related Stocks

- [301117.CN](https://longbridge.com/en/quote/301117.CN.md)
- [600718.CN](https://longbridge.com/en/quote/600718.CN.md)
- [300078.CN](https://longbridge.com/en/quote/300078.CN.md)
- [300253.CN](https://longbridge.com/en/quote/300253.CN.md)
- [000503.CN](https://longbridge.com/en/quote/000503.CN.md)
- [300074.CN](https://longbridge.com/en/quote/300074.CN.md)

## Related News & Research

- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [09:00 ETSickSlip Expands Beyond Doctor's Notes Into Sports Physicals, HSA/FSA Letters, and Dive Medicals](https://longbridge.com/en/news/297329784.md)
- [AI turns up a promising finding in cancer data that researchers hadn’t noticed for years](https://longbridge.com/en/news/297215988.md)
- [izmo Microsystems Develops Indigenous 40 GHz RF Semiconductor Package for Defence and Secure Communication Applications](https://longbridge.com/en/news/297629747.md)
- [FDA approves PharmaEssentia BESREMi for adults with essential thrombocythemia](https://longbridge.com/en/news/297513690.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**